Thiamine Hydrochloride 3000 mg/30 mL
Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.
Every FDA drug recall initiated in 2022, newest first, with its risk class, status and the reason the FDA recorded. Use the cause and risk filters to narrow the year down.
1,390 recalls, newest first.
Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.
Presence of Particulate Matter: Presence of foreign substances were reported in vials at the pharmacy.
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
Failed Excipient Specifications: out of specification result observed for p-Hydroxybenzoic Acid content
Subpotent Drug: repackaged product was recalled by the manufacturer for subpotency.
Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.
Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.
Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.
Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.
Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.
Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.
Presence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.
Labeling: Label Error on Declared Strength: syringes mislabeled as 300 mg iodine/mL contained product 350 mg iodine/mL
Presence of foreign substance
Labeling mixup: cartons labeled as Daptomycin 350 mg/vial were found to contain vials of Daptomycin 500 mg per vial
Underfilled units.
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.
Defective Container: Complaints received of vial breakage and glass flying when pressurized while preparing the product for administration.
Lack of sterility assurance: Bags have the potential to leak.
Subpotent Drug
Subpotent Drug: Testing results below the defined limit for the epinephrine portion of this product.